Oncolytic viruses (OVs) represent a promising therapeutic approach for cancer treatment.

Oncolytic virotherapy involves using genetically modified or naturally occurring viruses to specifically target and eradicate cancerous cells, while minimizing harm to normal, healthy cells.

The oncolytic bacteria product, SGN1, is a genetically engineered attenuated Salmonella strain that overexpresses an L-methioninase, which can specifically target and reduce methionine supply within …

Therefore, this commentary discusses the broad effects and perspectives of oncolytic peptides on anticancer immunity, further highlighting the potential issues and directions of oncolytic peptides in …

Oncolytic viruses (OVs) preferentially infect tumor cells and can be utilized for cancer therapy.

Oncolytic viruses represent a distinct class of viruses that selectively infect and destroy tumor cells while sparing normal cells. Despite their potential, oncolytic viruses encounter several challenges as …

Oncolytic viruses are a versatile therapeutic platform capable of exert-ing antitumour activity through multiple mechanisms. First, onco-lytic viruses can preferentially infect, replicate in...